If you maintain the 72-hour gap, you are unlikely to experience a significant increase in side effects
Even in severe VHT, the prognosis seems to be improved if VPA therapy is promptly discontinued [62]
Nizari S, Basalay M, Chapman P, Korte N, Korsak A, Christie IN, Theparambil SM, Davidson SM, Reimann F, Trapp S, Yellon DM, Gourine AV (2021) Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke
Patients with certain GLP1R variants may experience more nausea initially but adapt faster, while others benefit from slower titration or alternative compounds
Each capsule is precisely dosed and tested for consistency
The adjustments needed are in the supporting strategies, not the medication itself